What does CUSIP 36254L209 represent in this 13F holders report?

CUSIP 36254L209 is the security identifier for GTBP - GT BIOPHARMA INC - COM NEW used to aggregate holder disclosures.

How many institutions held GTBP - GT BIOPHARMA INC - COM NEW in Q1 2023?

32 institutional investors reported GTBP - GT BIOPHARMA INC - COM NEW for Q1 2023. Use the holders table for investor-level position and value details.

GT BIOPHARMA INC - COM NEW (GTBP)

CUSIP: 36254L209

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COM NEW
Total 13F shares: 4,968,875
Total 13F value: $2,732,824
Share change: -1,373,672
Put/Call ratio: 15%
SEC-reported price per share: $0.55
Number of holders: 32
Value change: -$749,578
Number of buys: 13
Number of sells: 10

Security key

36254L209

Report period

Q1 2023

Institutions

Top holders

GTBP full security history Ownership snapshot Full 13F holder table GT Biopharma, Inc. SEC filings GT Biopharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GTBP - GT BIOPHARMA INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

0/15

Latest evidence

31 Dec 2022

13F Highest disclosed value: $3,002,523 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $3M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Disclosed position value Top 5

ARMISTICE CAPITAL, LLC $3M

VANGUARD GROUP INC $998.5K

BlackRock Finance, Inc. $330.2K

ROYAL BANK OF CANADA $250K

GEODE CAPITAL MANAGEMENT, LLC $199K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$3,002,523 3,390,000 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$998,543 1,127,405 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$330,183 372,793 shares	—	31 Dec 2022
ROYAL BANK OF CANADA	13F Company 13F	— denominator unverified	$250,000 281,958 shares	—	31 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$199,000 223,444 shares	—	31 Dec 2022
Baskin Financial Services Inc.	13F Company 13F	— denominator unverified	$134,000 151,354 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

4,968,875

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %